These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 14674605)

  • 21. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
    Nettelbeck DM; Rivera AA; Balagué C; Alemany R; Curiel DT
    Cancer Res; 2002 Aug; 62(16):4663-70. PubMed ID: 12183423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells.
    Rothmann T; Hengstermann A; Whitaker NJ; Scheffner M; zur Hausen H
    J Virol; 1998 Dec; 72(12):9470-8. PubMed ID: 9811680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditionally replicating adenoviruses for cancer treatment.
    Jounaidi Y; Doloff JC; Waxman DJ
    Curr Cancer Drug Targets; 2007 May; 7(3):285-301. PubMed ID: 17504125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein.
    Doronin K; Toth K; Kuppuswamy M; Ward P; Tollefson AE; Wold WS
    J Virol; 2000 Jul; 74(13):6147-55. PubMed ID: 10846098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro primary cell culture as a physiologically relevant method for preclinical testing of human oncolytic adenovirus.
    Adamson RE; Frazier AA; Evans H; Chambers KF; Schenk E; Essand M; Birnie R; Mitry RR; Dhawan A; Maitland NJ
    Hum Gene Ther; 2012 Feb; 23(2):218-30. PubMed ID: 21823897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors.
    Wang Y; Xue SA; Hallden G; Francis J; Yuan M; Griffin BE; Lemoine NR
    Cancer Res; 2005 Feb; 65(4):1523-31. PubMed ID: 15735041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic adenoviruses: design, generation, and experimental procedures.
    Davydova J; Yamamoto M
    Curr Protoc Hum Genet; 2013 Jul; Chapter 12():Unit 12.14. PubMed ID: 23853080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication and virus-induced transcriptome of HAdV-5 in normal host cells versus cancer cells--differences of relevance for adenoviral oncolysis.
    Dorer DE; Holtrup F; Fellenberg K; Kaufmann JK; Engelhardt S; Hoheisel JD; Nettelbeck DM
    PLoS One; 2011; 6(11):e27934. PubMed ID: 22140489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling heterogeneity in viral-tumour dynamics: The effects of gene-attenuation on viral characteristics.
    Jenner A; Yun CO; Yoon A; Kim PS; Coster ACF
    J Theor Biol; 2018 Oct; 454():41-52. PubMed ID: 29857083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.
    Wills KN; Maneval DC; Menzel P; Harris MP; Sutjipto S; Vaillancourt MT; Huang WM; Johnson DE; Anderson SC; Wen SF
    Hum Gene Ther; 1994 Sep; 5(9):1079-88. PubMed ID: 7833367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
    Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS
    Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-based cancer gene therapy.
    Kaplan JM
    Curr Gene Ther; 2005 Dec; 5(6):595-605. PubMed ID: 16457649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic adenovirus characterization: activity and immune responses.
    Gil-Hoyos R; Miguel-Camacho J; Alemany R
    Methods Mol Biol; 2014; 1089():117-32. PubMed ID: 24132482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
    Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
    J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer.
    Thorne SH; Brooks G; Lee YL; Au T; Eng LF; Reid T
    J Virol; 2005 Jan; 79(1):581-91. PubMed ID: 15596850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.